1. Home
  2. SCVL vs BCAX Comparison

SCVL vs BCAX Comparison

Compare SCVL & BCAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SCVL
  • BCAX
  • Stock Information
  • Founded
  • SCVL 1978
  • BCAX 2018
  • Country
  • SCVL United States
  • BCAX United States
  • Employees
  • SCVL N/A
  • BCAX N/A
  • Industry
  • SCVL Clothing/Shoe/Accessory Stores
  • BCAX
  • Sector
  • SCVL Consumer Discretionary
  • BCAX
  • Exchange
  • SCVL Nasdaq
  • BCAX NYSE
  • Market Cap
  • SCVL 481.8M
  • BCAX 541.0M
  • IPO Year
  • SCVL 1993
  • BCAX 2024
  • Fundamental
  • Price
  • SCVL $22.28
  • BCAX $11.75
  • Analyst Decision
  • SCVL Strong Buy
  • BCAX Strong Buy
  • Analyst Count
  • SCVL 1
  • BCAX 7
  • Target Price
  • SCVL $51.00
  • BCAX $29.17
  • AVG Volume (30 Days)
  • SCVL 422.2K
  • BCAX 528.6K
  • Earning Date
  • SCVL 09-04-2025
  • BCAX 08-16-2025
  • Dividend Yield
  • SCVL 2.69%
  • BCAX N/A
  • EPS Growth
  • SCVL N/A
  • BCAX N/A
  • EPS
  • SCVL 2.39
  • BCAX N/A
  • Revenue
  • SCVL $1,180,235,000.00
  • BCAX N/A
  • Revenue This Year
  • SCVL N/A
  • BCAX N/A
  • Revenue Next Year
  • SCVL $3.11
  • BCAX N/A
  • P/E Ratio
  • SCVL $9.32
  • BCAX N/A
  • Revenue Growth
  • SCVL N/A
  • BCAX N/A
  • 52 Week Low
  • SCVL $16.14
  • BCAX $7.80
  • 52 Week High
  • SCVL $46.92
  • BCAX $28.09
  • Technical
  • Relative Strength Index (RSI)
  • SCVL 60.57
  • BCAX N/A
  • Support Level
  • SCVL $20.02
  • BCAX N/A
  • Resistance Level
  • SCVL $23.61
  • BCAX N/A
  • Average True Range (ATR)
  • SCVL 0.86
  • BCAX 0.00
  • MACD
  • SCVL 0.14
  • BCAX 0.00
  • Stochastic Oscillator
  • SCVL 62.95
  • BCAX 0.00

About SCVL Shoe Carnival Inc.

Shoe Carnival Inc is a family footwear retailer that offers a broad assortment of dress, casual, and athletic footwear for men, women, and children with an emphasis on national name brands such as Nike, Skechers, Adidas, Puma, HEYDUDE, Converse, Vans, and Crocs. The company operates its business as one reportable segment based on the similar nature of products sold; merchandising, distribution, and marketing processes involved; target customers; and economic characteristics of stores and e-commerce platforms. Its bricks-first, omnichannel approach provides customers easy access to a wide assortment of branded footwear for work, athletics, daily activities, and special events via a choice of delivery channels.

About BCAX BICARA THERAPEUTICS INC

Bicara Therapeutics Inc is a clinical-stage biopharmaceutical company bringing transformative bifunctional therapies to patients with solid tumors. Its program ficerafusp alfa is a bifunctional antibody that combines two clinically validated targets, an epidermal growth factor receptor, or EGFR, directed monoclonal antibody with a domain that binds to human transforming growth factor beta, or TGF-b.

Share on Social Networks: